Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
391
datasets available to search
ShareScore release 0.9.0
Dataset results
391 results for “Antiretroviral therapy”
Adherence and Risk Behaviour in Patients With HIV Infection Receiving Antiretroviral Therapy
ClinicalTrials.gov study NCT00511056. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Optimizing Antiretroviral Therapy in HIV-Infected Children and Adolescents
ClinicalTrials.gov study NCT00207948. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Routine Use of Antiretroviral Therapy to Prevent Mother-to-Child HIV Transmission in the Kafue District of Zambia
ClinicalTrials.gov study NCT00753324. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Advanced HIV Disease During the First Six Months on Antiretroviral Therapy in Zambia
ClinicalTrials.gov study NCT06904456. IPD Sharing: YES. Countries: 1. Publications: 1.
Early Intensification of Antiretroviral Therapy Including Enfuvirtide in HIV-1-Related Progressive Multifocal Leucoencephalopathy (ANRS125)
ClinicalTrials.gov study NCT00120367. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effectiveness of Antiretroviral Therapy During Acute HIV Infection
ClinicalTrials.gov study NCT00705926. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Postpartum Adherence Clubs for Antiretroviral Therapy
ClinicalTrials.gov study NCT03200054. IPD Sharing: NO. Countries: 1. Publications: 5.
Strategies to Optimize Antiretroviral Therapy Services for Maternal & Child Health: the MCH-ART Study
ClinicalTrials.gov study NCT01933477. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Data from: Optimizing prevention of HIV mother to child transmission: duration of antiretroviral therapy and viral suppression at delivery among pregnant Malawian women
Open the record for dataset details and reuse information.
Data from: Initiating Antiretroviral Therapy for HIV at a Patient’s First Clinic Visit: The RapIT Randomized Controlled Trial
Open the record for dataset details and reuse information.
Data from: Early antiretroviral therapy and potent second-line drugs could decrease HIV incidence of drug resistance
Early initiation of antiretroviral therapy (ART) reduces the risk of drug-sensitive HIV transmission but may increase the transmission of drug-resistant HIV. We used a mathematical model to estimate the long-term population-level benefits of ART and determine the scenarios under which earlier ART (treatment at 1 year post-infection, on average) could decrease simultaneously both total and drug-resistant HIV incidence (new infections). We constructed an infection-age-structured mathematical model that tracked the transmission rates over the course of infection and modelled the patients' life expectancy as a function of ART initiation timing. We fitted this model to the annual AIDS incidence and death data directly, and to resistance data and demographic data indirectly among men who have sex with men (MSM) in San Francisco. Using counterfactual scenarios, we assessed the impact on total and drug-resistant HIV incidence of ART initiation timing, frequency of acquired drug resistance, and second-line drug effectiveness (defined as the combination of resistance monitoring, biomedical drug efficacy and adherence). Earlier ART initiation could decrease the number of both total and drug-resistant HIV incidence when second-line drug effectiveness is sufficiently high (greater than 80%), but increase the proportion of new infections that are drug resistant. Thus, resistance may paradoxically appear to be increasing while actually decreasing.
Viral suppression after transition from nonnucleoside reverse transcriptase inhibitor- to dolutegravir-based antiretroviral therapy: A prospective cohort study in Lesotho (DO-REAL study)
<p>Pseudonymized dataset for the published manuscript "Viral suppression after transition from nonnucleoside reverse transcriptase inhibitor- to dolutegravir-based antiretroviral therapy: A prospective cohort study in Lesotho (DO-REAL study)"</p>
Dihydroartemisinin-Piperaquine in the Context of Antiretroviral Therapy
ClinicalTrials.gov study NCT04487145. IPD Sharing: NO. Countries: 1. Publications: 0.
Social Networks and Methadone Maintenance Treatment Retention and Antiretroviral Therapy Retention in Tanzania
ClinicalTrials.gov study NCT04479475. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy (ART)
ClinicalTrials.gov study NCT02440789. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients
ClinicalTrials.gov study NCT00234923. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Safety and Efficacy of Tenofovir DF in HIV-1 Infected Adolescents Failing Their Current Antiretroviral Therapy
ClinicalTrials.gov study NCT00352053. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study of MGD020 Alone or Combined With MGD014 in Persons With HIV-1 on Antiretroviral Therapy
ClinicalTrials.gov study NCT05261191. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dose-finding Study of GSK2248761 in Antiretroviral Therapy-experienced Subjects With NNRTI-resistant HIV Infection
ClinicalTrials.gov study NCT01199731. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral Therapy in Persons With Advanced HIV Infection
ClinicalTrials.gov study NCT00885664. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.